Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2009, Volume 16, Issue 06, pages 257-304

EDITORIAL
Br J Cardiol 2009;16:265–7

The use of risk scores for stratification of acute coronary syndrome patients

Although patients with acute coronary syndrome (ACS) share key pathophysiological mechanisms, they present with diverse clinical, electrocardiographic and enzyme characteristics and experience a wide range...

Read More

NEWS
Br J Cardiol 2009;16:269-71

Pericardial fat – a good predictor of future heart disease

Fat around the heart— known as pericardial fat— may be a better predictor of future heart disease than either body mass index (BMI) or waist...

Read More

NEWS
Br J Cardiol 2009;16:269-71

CHD risk is being overestimated in diabetes

The Framingham and UKPDS (United Kingdom Prospective Diabetes Study) risk equations overestimate the probability of cardiovascular events in people with type 2 diabetes, according to...

Read More

NEWS
Br J Cardiol 2009;16:269-71

New Bluetooth stethoscope available

A new stethoscope – the Littmann 3200 – is now available which is the first to enable Bluetooth transfer of sounds to software for storage...

Read More

NEWS
Br J Cardiol 2009;16:269-71

Hypothermia improves outcomes after cardiac arrest

Conventional cooling methods can improve survival and reduce neurologic injury after cardiac arrest, a new Cochrane Review...

Read More

NEWS
Br J Cardiol 2009;16:269-71

BLOSSOM: new weight loss drug on the horizon

A new drug, lorcaserin, showed good weight loss results without the valvular side-effects associated with some other serotonin type agents in the Phase III Blossom...

Read More

NEWS
Br J Cardiol 2009;16:269-71

NT-proBNP predicts atrial fibrillation

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a “remarkable predictor” of incident atrial fibrillation (AF), even after adjustment for other known risk factors, according to the...

Read More

NEWS
Br J Cardiol 2009;16:269-71

Increasing treatment window for tPA in stroke

New analyses of data from ECASS 3 (Third European Cooperative Acute Stroke Study) suggest that the thrombolytic, tPA (alteplase) has benefits in the treatment of...

Read More

NEWS
Br J Cardiol 2009;16:269-71

Clopidogrel needed for more than one year after drug-eluting stent placement?

Extending clopidogrel treatment from one to two years after drug-eluting stent placement is associated with a reduction in very late thromboses, new registry data suggest....

Read More

NEWS
Br J Cardiol 2009;16:269-71

Niacin shows plaque regression

The use of niacin was associated with a regression of atherosclerotic plaque in a new imaging...

Read More

IN BRIEF
Br J Cardiol 2009;16:272

In brief

Seven million in UK have prediabetes An estimated seven million people in the UK have prediabetes (or impaired glucose regulation), according to Diabetes UK. The...

Read More

MEETING REPORT
Br J Cardiol 2009;16:273

News from TCT 2009

The Transcatheter Cardiovascular Therapeutics 2009 meeting was held in San Francisco, USA, from September 22nd –...

Read More

MEETING REPORT
Br J Cardiol 2009;16:274-5

From rheumatic fever to atrial ablation: reconciling needs and availability of healthcare globally

Colin Doig and Henry Purcell report highlights from the recent Cardiology at the Limits meeting held in Cape Town, South...

Read More

MEETING REPORT
Br J Cardiol 2009;16:276-7

Making change happen: the PCCS Annual Scientific Meeting

‘Making change happen’ was the theme of the 12th Annual Scientific Meeting of the Primary Care Cardiovascular Society (PCCS) in Nottingham on 1st – 3rd...

Read More

OBLIQUE VIEW
Br J Cardiol 2009;16:278-9

Hey ho for the open road

We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,...

Read More

CLINICAL ARTICLE
Br J Cardiol 2009;16:281-6

Pharmaceutical salts: a formulation trick or a clinical conundrum?

The term pharmaceutical salt is used to refer to an ionisable drug that has been combined with a counter-ion to form a neutral complex. Converting...

Read More

CLINICAL ARTICLE
Br J Cardiol 2009;16:288-91

10 steps before you refer for peripheral arterial disease

Peripheral arterial disease (PAD) is a condition that is frequently underdiagnosed and often the subject of suboptimal care. It can present with rest pain or...

Read More

CLINICAL ARTICLE
Br J Cardiol 2009;16:292–4

The joint cardiology–cardiothoracic multi-disciplinary team (MDT) meeting: patient characteristics and revascularisation outcomes

The multi-disciplinary approach provides a forum for peer review of angiographic data. We aimed to examine the outcomes of our multi-disciplinary team (MDT) meetings in...

Read More

CLINICAL ARTICLE
Br J Cardiol 2009;16:295–8

Colesevelam – where does it fit into our clinical practice?

The treatment of raised cholesterol has advanced significantly in the last 25 years: fibrates, statins, bile acid sequestrants, ezetimibe, and more. In October 2007, colesevelam...

Read More

CLINICAL ARTICLE
Br J Cardiol 2009;16:299–302

Lifespan and cardiology

We undertook a seven-year in-depth review of all reported obituaries of medical practitioners in the BMJ to assess the age and disease distribution of mortality...

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits